These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16153449)

  • 1. PJ34, a poly-ADP-ribose polymerase inhibitor, modulates renal injury after thoracic aortic ischemia/reperfusion.
    Stone DH; Al-Badawi H; Conrad MF; Stoner MC; Entabi F; Cambria RP; Watkins MT
    Surgery; 2005 Aug; 138(2):368-74. PubMed ID: 16153449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion.
    Black JH; Casey PJ; Albadawi H; Cambria RP; Watkins MT
    J Am Coll Surg; 2006 Jul; 203(1):44-53. PubMed ID: 16798486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(adenosine diphosphate ribose) polymerase inhibition modulates spinal cord dysfunction after thoracoabdominal aortic ischemia-reperfusion.
    Casey PJ; Black JH; Szabo C; Frosch M; Albadawi H; Chen M; Cambria RP; Watkins MT
    J Vasc Surg; 2005 Jan; 41(1):99-107. PubMed ID: 15696051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PJ34, a poly-ADP-ribose polymerase inhibitor, modulates visceral mitochondrial activity and CD14 expression following thoracic aortic ischemia-reperfusion.
    Stone DH; Albadawi H; Conrad MF; Entabi F; Stoner MC; Casey PJ; Cambria RP; Watkins MT
    Am J Surg; 2009 Aug; 198(2):250-5. PubMed ID: 19268911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of PJ34 on spinal cord tissue viability and gene expression in a murine model of thoracic aortic reperfusion injury.
    Stone DH; Conrad MF; Albadawi H; Entabi F; Stoner MC; Cambria RP; Watkins MT
    Vasc Endovascular Surg; 2009; 43(5):444-51. PubMed ID: 19640911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyadenosine diphosphate-ribose polymerase inhibition modulates skeletal muscle injury following ischemia reperfusion.
    Hua HT; Albadawi H; Entabi F; Conrad M; Stoner MC; Meriam BT; Sroufe R; Houser S; Lamuraglia GM; Watkins MT
    Arch Surg; 2005 Apr; 140(4):344-51; discussion 351-2. PubMed ID: 15837884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local administration of the Poly ADP-Ribose Polymerase (PARP) inhibitor, PJ34 during hindlimb ischemia modulates skeletal muscle reperfusion injury.
    Conrad MF; Albadawi H; Stone DH; Crawford RS; Entabi F; Watkins MT
    J Surg Res; 2006 Oct; 135(2):233-7. PubMed ID: 16872633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats.
    Lenzsér G; Kis B; Snipes JA; Gáspár T; Sándor P; Komjáti K; Szabó C; Busija DW
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1318-26. PubMed ID: 17213862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postischemic poly (ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hind-limb ischemia model.
    Crawford RS; Albadawi H; Atkins MD; Jones JE; Yoo HJ; Conrad MF; Austen WG; Watkins MT
    Surgery; 2010 Jul; 148(1):110-8. PubMed ID: 20132957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly-ADP-ribose-polymerase inhibition ameliorates hind limb ischemia reperfusion injury in a murine model of type 2 diabetes.
    Long CA; Boulom V; Albadawi H; Tsai S; Yoo HJ; Oklu R; Goldman MH; Watkins MT
    Ann Surg; 2013 Dec; 258(6):1087-95. PubMed ID: 23549425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.
    Jagtap P; Soriano FG; Virág L; Liaudet L; Mabley J; Szabó E; Haskó G; Marton A; Lorigados CB; Gallyas F; Sümegi B; Hoyt DG; Baloglu E; VanDuzer J; Salzman AL; Southan GJ; Szabó C
    Crit Care Med; 2002 May; 30(5):1071-82. PubMed ID: 12006805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor.
    Faro R; Toyoda Y; McCully JD; Jagtap P; Szabo E; Virag L; Bianchi C; Levitsky S; Szabo C; Sellke FW
    Ann Thorac Surg; 2002 Feb; 73(2):575-81. PubMed ID: 11845877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice.
    El Amki M; Lerouet D; Garraud M; Teng F; Beray-Berthat V; Coqueran B; Barsacq B; Abbou C; Palmier B; Marchand-Leroux C; Margaill I
    Mol Neurobiol; 2018 Dec; 55(12):9156-9168. PubMed ID: 29651748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of PJ-34 PARP-inhibitor on rat liver microcirculation and antioxidant status.
    Szijártó A; Batmunkh E; Hahn O; Mihály Z; Kreiss A; Kiss A; Lotz G; Schaff Z; Váli L; Blázovics A; Geró D; Szabó C; Kupcsulik P
    J Surg Res; 2007 Sep; 142(1):72-80. PubMed ID: 17612561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice.
    Haddad M; Rhinn H; Bloquel C; Coqueran B; Szabó C; Plotkine M; Scherman D; Margaill I
    Br J Pharmacol; 2006 Sep; 149(1):23-30. PubMed ID: 16865091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice.
    Tao X; Chen X; Hao S; Hou Z; Lu T; Sun M; Liu B
    Neuroscience; 2015 Apr; 291():26-36. PubMed ID: 25668593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury.
    Mori K; Lee HT; Rapoport D; Drexler IR; Foster K; Yang J; Schmidt-Ott KM; Chen X; Li JY; Weiss S; Mishra J; Cheema FH; Markowitz G; Suganami T; Sawai K; Mukoyama M; Kunis C; D'Agati V; Devarajan P; Barasch J
    J Clin Invest; 2005 Mar; 115(3):610-21. PubMed ID: 15711640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation.
    Szabó G; Bährle S; Stumpf N; Sonnenberg K; Szabó E E; Pacher P; Csont T; Schulz R; Dengler TJ; Liaudet L; Jagtap PG; Southan GJ; Vahl CF; Hagl S; Szabó C
    Circ Res; 2002 Jan; 90(1):100-6. PubMed ID: 11786525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The poly(adenosine diphosphate-ribose) polymerase inhibitor PJ34 reduces pulmonary ischemia-reperfusion injury in rats.
    Hatachi G; Tsuchiya T; Miyazaki T; Matsumoto K; Yamasaki N; Okita N; Nanashima A; Higami Y; Nagayasu T
    Transplantation; 2014 Sep; 98(6):618-24. PubMed ID: 25221900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition.
    Ko GJ; Grigoryev DN; Linfert D; Jang HR; Watkins T; Cheadle C; Racusen L; Rabb H
    Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1472-83. PubMed ID: 20181666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.